Mitchell Machtay
Department of Radiation Oncology
University of Pennsylvania
Philadelphia 19104
USA
Name/email consistency: high
- Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay, M., Lee, J.H., Stevenson, J.P., Shrager, J.B., Algazy, K.M., Treat, J., Kaiser, L.R. J. Thorac. Cardiovasc. Surg. (2004)
- Complex and controversial issues in locally advanced non-small cell lung carcinoma. Machtay, M., Jeremic, B. Semin. Surg. Oncol (2003)
- Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. Machtay, M., Rosenthal, D.I., Hershock, D., Jones, H., Williamson, S., Greenberg, M.J., Weinstein, G.S., Aviles, V.M., Chalian, A.A., Weber, R.S. J. Clin. Oncol. (2002)
- Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. Machtay, M., Lee, J.H., Shrager, J.B., Kaiser, L.R., Glatstein, E. J. Clin. Oncol. (2001)
- A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. Machtay, M., Aviles, V., Kligerman, M.M., Treat, J., Weinstein, G.S., Weber, R.S., Mirza, N., Chalian, A.A., Rosenthal, D.I. Int. J. Radiat. Oncol. Biol. Phys. (1999)